The U.S. healthcare system is full of administrative inefficiencies that reduce quality and affordability, and is run down by flawed billing practices, made worse by opaque and complex coverage benefits. The result is a system that patients struggle to afford and find challenging to navigate for a clear solution.
Claritev aims to bring the transparency our nation needs to see its way to a better healthcare system. We work across the healthcare value chain to address imbalanced, inefficient pricing practices. As a healthcare technology, data and insights company, Claritev is focused on making healthcare more transparent, fair and affordable for all.
The demand for cost-effective, data-driven healthcare solutions is accelerating across the world. We’re actively expanding our international presence, recently entering strategic partnerships in the Middle East. Our global strategy enhances our ability to serve diverse markets and unlock new revenue streams.
Creating healthcare clarity for over 45 years.
At the end of every healthcare decision is a person — a patient wanting to access care without confusion or unexpected costs. We exist to help make healthcare data clearer, so the system can work better for everyone.
For decades, Claritev has been helping organizations across the healthcare ecosystem make better decisions by bringing clarity to complex healthcare data. With technology and AI solutions, we help make costs, pricing, and payment dynamics easier to understand and navigate.
Please visit https://www.claritev.com/who-we-are/ for more information about Who We Are.
Our headquarters are located at 7900 Tysons One Place, Suite 400, McLean, Virginia 22102.
Claritev’s leadership includes its executive management team and board of directors. Biographies, roles, and governance information are available on Claritev’s Investor Relations pages for executive management and the board of directors.
Claritev’s fiscal year ends December 31.
Claritev’s Class A common stock began trading on the New York Stock Exchange under the ticker symbol “MPLN” on October 8, 2020. On February 17, 2025, the Company changed its name from “MultiPlan Corporation” to “Claritev Corporation”. Effective February 28, 2025, the Company began trading under a new ticker symbol of “CTEV” on the New York Stock Exchange.
Claritev’s common shares can be purchased in the open market through any registered broker.
Claritev does not currently anticipate paying any dividends on its common shares. The declaration, amount and payment of any future dividends on its common shares will be at the sole discretion of its board of directors.
The CUSIP for the Class A Common is: 62548M209.
Claritev’s transfer agent is Continental Stock Transfer & Trust Company. It can be reached using the contact information below:
Continental Stock Transfer & Trust Company
1 State Street, 30th Floor
New York, NY 10004
(212) 509-4000
You can contact Claritev’s Investor Relations team by email at investor@claritev.com.
Information about Claritev’s next earnings release can be viewed, when available, by visiting the Events & Presentations section of the company’s investor relations website or by clicking here.
SEC filings, including quarterly and annual reports, can be accessed on the Investor Relations section of Claritev’s website or by clicking here. SEC filings can also be accessed directly from the SEC: www.sec.gov.
You can register your email address by signing up to receive email alerts, here.
Information about Claritev’s Annual Stockholders’ meeting will be available in a Form Def 14A proxy statement filing with the SEC.
Please go to the email alerts section of our website or click here.
Claritev’s latest corporate-related press releases can be accessed at Claritev’s Newsroom.